|
Index of reports
> Cases resulting in a serious event (103)
> Cases with Hepatitis (7)
Below is the selection of adverse event reports related to Mobic (Meloxicam) that includes cases resulting in a serious event where reactions include hepatitis.
Adverse event in 55 year old female receiving Mobic (Meloxicam)
Reported by a pharmacist from United States on 2007-06-01
Patient: 55 year old female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Weight Decreased, Hepatitis C Antibody Positive, Dizziness Exertional, Chills, Blood Thyroid Stimulating Hormone Increased, Hepatitis, Weight Increased, Herpes Simplex DNA Test Positive, Fatigue, Skin Lesion, Oedema Peripheral, Liver Function Test Abnormal, Cold Sweat, Blister, Blood Urine Present, Urinary Tract Infection, Rash, Tenosynovitis, Burning Sensation, Fungal Infection, Memory Impairment, Asthenia, Influenza Like Illness
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Mobic (Meloxicam)
Other drugs received by patient: Klonopin; Adderall 10; Zelnorm; Synthroid; Seroquel
Adverse event in male receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-04-20
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Acute Hepatic Failure, Hepatitis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in male receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-04-10
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Acute Hepatic Failure, Hepatitis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in male receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-04-06
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Acute Hepatic Failure, Hepatitis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in 69 year old female receiving Mobic (Meloxicam)
Reported by a physician from Japan on 2007-03-09
Patient: 69 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Hepatitis
Suspect drug(s):
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2007-01-01
End date: 2007-02-20
Onealfa
Administration route: Oral
Indication: Osteoporosis
Start date: 2007-01-01
End date: 2007-02-20
Mobic
Administration route: Oral
Indication: Analgesic Effect
Start date: 2007-01-01
End date: 2007-02-20
Other drugs received by patient: Intedaru; Cibenol; Gastromet; Cerocral; Nitrazepam; Depas; Sucralfate; Sifrol
Adverse event in male receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-03-07
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Hepatitis Cholestatic, Hepatitis, Nephritis
Adverse event resulted in: life threatening event
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Osteoarthritis
Start date: 2000-06-15
End date: 2006-08-15
Atacand
Administration route: Oral
Indication: Essential Hypertension
Start date: 2005-06-15
End date: 2006-08-15
Sildenafil Citrate
Administration route: Oral
Indication: Somatoform Disorder
Start date: 2003-06-15
End date: 2006-08-15
Atenolol
Administration route: Oral
Indication: Essential Hypertension
Start date: 2004-06-15
End date: 2006-08-15
Atorvastatin
Administration route: Oral
Indication: Metabolic Disorder
Start date: 2004-06-15
End date: 2006-08-15
Rabeprazole Sodium
Administration route: Oral
Indication: Oesophageal Disorder
Start date: 2005-07-15
End date: 2006-08-15
Adverse event in male receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-03-02
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Hepatitis Cholestatic, Hepatitis, Nephritis
Adverse event resulted in: life threatening event
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Osteoarthritis
Start date: 2000-06-15
End date: 2006-08-15
Atacand
Administration route: Oral
Indication: Somatoform Disorder
Start date: 2005-06-15
End date: 2006-08-15
Sildenafil Citrate
Administration route: Oral
Indication: Essential Hypertension
Start date: 2003-06-15
End date: 2006-08-15
Atenolol
Administration route: Oral
Indication: Metabolic Disorder
Start date: 2004-06-15
End date: 2006-08-15
Atorvastatin
Administration route: Oral
Indication: Essential Hypertension
Start date: 2004-06-15
End date: 2006-08-15
Rabeprazole Sodium
Administration route: Oral
Indication: Oesophageal Disorder
Start date: 2005-07-15
End date: 2006-08-15
|
